Chemoinformaics analysis of GRAVEOBIOSIDE-B
Molecular Weight | 594.522 | nRot | 8 |
Heavy Atom Molecular Weight | 564.282 | nRig | 29 |
Exact Molecular Weight | 594.158 | nRing | 5 |
Solubility: LogS | -3.545 | nHRing | 3 |
Solubility: LogP | -0.132 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
nHA | 15 | APOL | 77.1238 |
nHD | 8 | BPOL | 41.3802 |
QED | 0.148 |
Synth | 4.684 |
Natural Product Likeliness | 2.191 |
NR-PPAR-gamma | 0.939 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.988 |
HIA | 0.975 |
CACO-2 | -6.3 |
MDCK | 0.0000439 |
BBB | 0.201 |
PPB | 0.744785 |
VDSS | 0.6 |
FU | 0.170293 |
CYP1A2-inh | 0.019 |
CYP1A2-sub | 0.122 |
CYP2c19-inh | 0.007 |
CYP2c19-sub | 0.061 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.108 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.185 |
CYP3a4-inh | 0.033 |
CYP3a4-sub | 0.033 |
CL | 2.25 |
T12 | 0.456 |
hERG | 0.055 |
Ames | 0.59 |
ROA | 0.023 |
SkinSen | 0.046 |
Carcinogencity | 0.513 |
EI | 0.006 |
Respiratory | 0.022 |
NR-Aromatase | 0.943 |
Antiviral | Yes |
Prediction | 0.825609 |